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Luminal leptin inhibits L-glutamine transport in rat small intestine:
involvement of ASCT2 and B0AT1. Am J Physiol Gastrointest Liver
Physiol 299: G179–G185, 2010. First published May 6, 2010;
doi:10.1152/ajpgi.00048.2010.—L-glutamine is the primary metabolic
fuel for enterocytes. Glutamine from the diet is transported into the
absorptive cells by two sodium-dependent neutral amino acid trans-
porters present at the apical membrane: ASCT2/SLC1A5 and B0AT1/
SLC6A19. We have demonstrated that leptin is secreted into the
stomach lumen after a meal and modulates the transport of sugars
after binding to its receptors located at the brush border of the
enterocytes. The present study was designed to address the effect of
luminal leptin on Na-dependent glutamine (Gln) transport in rat
intestine and identify the transporters involved. We found that 0.2 nM
leptin inhibited uptake of Gln and phenylalanine (Phe) (substrate of
B0AT1) using everted intestinal rings. In Ussing chambers, 10 mM
Gln absorption followed as Na-induced short-circuit current was
inhibited by leptin in a dose-dependent manner (maximum inhibition
at 10 nM; IC50  0.1 nM). Phe absorption was also decreased by
leptin. Western blot analysis after 3-min incubation of the intestinal
loops with 10 mM Gln, showed marked increase of ASCT2 and
B0AT1 protein in the brush-border membrane that was reduced by
rapid preincubation of the intestinal lumen with 1 nM leptin. Simi-
larly, the increase in ASCT2 and B0AT1 gene expression induced by
60-min incubation of the intestine with 10 mM Gln was strongly
reduced after a short preincubation period with leptin. Altogether
these data demonstrate that, in rat, leptin controls the active Gln entry
through reduction of both B0AT1 and ASCT2 proteins traffic to the
apical plasma membrane and modulation of their gene expression.
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GLUTAMINE (Gln) is the most abundant amino acid in the
plasma. It is absorbed by the intestine, making this organ a key
player in the whole body Gln homeostasis. As Gln is a
precursor of the nucleosides and glucose synthesis and is
involved in the acid-base balance in the kidney, it is crucial for
the interorgan nitrogen flux. Gln is also the most important
energy source for the enterocytes, lymphocytes, and fibroblasts
and is necessary for the growth and viability of cells main-
tained in culture (5). Gln from the diet is transported into the
enterocyte by two sodium-dependent neutral amino acid trans-
porters present in the apical membrane: ASCT2 (System ASC)
and B0AT1 (System B) (6). ASCT2/SLC1A5 shows high
affinity for alanine (Ala), serine, cysteine, threonine, and Gln
(K0.5 20 M), whereas B0AT1/ SLC6A19 is a low-affinity
transporter (K0.5 ranging from 1.4 to 4 mM) with preference for
large neutral amino acids, including those with bulky lateral
chain as phenylalanine (Phe), a specific substrate for this
transporter (6). In the cell, most of the Gln is metabolized to
cover its energetic requirements, and the rest is transported to
the blood by the basolateral sodium-independent exchanger
LAT-2/4F2hc, SLC7A8/SLC3A2 (system L) (6).
Leptin was initially described as an adipostatic signal con-
trolling food intake and energy expenditure (32). Today, it is
well known that leptin is a multifunctional hormone that is also
involved in immune and neuroendocrine functions and nutrient
absorption (22). This action is consistent with the production of
leptin by many other tissues (1, 15, 23), as well as the
expression of its receptors in peripheral tissues (14, 22). In-
deed, we have demonstrated that leptin receptor is expressed in
both the apical and basolateral membrane of intestinal absorp-
tive cells (3). Other authors also showed that leptin is secreted
into the gastric lumen after a meal by pepsinogen-containing
secretory granules of chief cells (11), which also contain the
leptin-soluble receptor, indicating that this leptin receptor iso-
form is also released into the gastric lumen (12). Bound to this
receptor, leptin remains stable in the gastric juice, despite the
severe conditions of pH and proteolytic activity in the gastric
lumen, and is able to reach the intestinal lumen (17). Accord-
ingly, we have demonstrated that leptin present in the intestinal
lumen inhibits sugar absorption in vivo by regulating the
Na/glucose cotransporter SGLT1 (19). A similar effect was
previously reported in vitro (2, 16, 18, 21) with implication of
both PKC and PKA activation (4, 16). Interestingly, luminal
leptin enhances the intestinal transport of dipeptides by the
H/peptide transporter PEPT1 and CD147/medium-chain tri-
glyceride (MCT)-1 mediated uptake of butyrate in mice and
Caco-2 cells (9, 10), as well as fructose transport by the
facilitative glucose transporter GLUT5 in rat intestine in vivo
(25). Given that leptin seems to regulate different nutrient
transporters, one could anticipate that it may also modulate
amino acid transporters in the intestine. However, there are not
data in this respect yet. Considering the importance of Gln for
the whole organism and in the intestine itself, the aim of the
present study was to investigate the effect of luminal leptin on
Gln transport and the target transporters of the hormone. We
found that both ASCT2 and B0AT1 are involved in Na-
dependent uptake of glutamine in rat intestine and regulated by
apical leptin. The present results give new insights into the role
of leptin as a major gastrointestinal hormone regulating intake
of rich energy molecules.
MATERIALS AND METHODS
Animals. Male Wistar rats weighing 220–260 g were obtained from
Charles River Laboratories, L’Arbresle, France and the Applied
Pharmacology Research Center (CIFA) of the University of Navarra,
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Pamplona, Spain. They were caged under standard laboratory condi-
tions with tap water and regular food provided ad libitum, in a
12-h:12-h light/dark cycle at a temperature of 21–23°C and fasted for
16–18 h, with free access to water, before the experiments. The
animals were treated in accordance with the European Community
Guidelines concerning the care and use of laboratory animals. The
animal studies were performed under license from the veterinary
department of Paris, France (to A. Bado and R. Ducroc, authorization
no. 75-955 of September 2, 2004, and no. 75-174 of October 9, 2003,
respectively; agreement no. B75-18-02; decision no. 05/12 established
on July 12, 2005 by Prefecture of Police de Paris, France). The
experimental protocol was approved by the Animal Research Ethic
Committee of the University of Navarra, with the no. 064-06.
Everted intestinal ring uptake assays. Rats were anesthetized by
intraperitoneal injection of a mixture (4:1) of ketamine chlorohydrate
(Ketolar; Merial S.A., Barcelona, Spain) and medetomidine chloro-
hydrate (Domtor; Pfizer Orion, Espoo, Finland), at a dose of 0.25 ml
per 100 g body wt. Uptake of Gln or Phe by everted jejunal rings was
determined as previously described (21). Briefly, rats were anesthe-
tized, and a segment (20–25 cm) of jejunum was quickly excised,
rinsed with ice cold saline solution (NaCl 0.9%), everted, and cut into
30-mg pieces. Groups of six rings were incubated for 15 min at
37°C under continuous shaking and gassed with O2, in Krebs-Ringer-
Tris containing 0.5 mM Gln or 50 M Gln (Sigma-Aldrich, St. Louis,
MO) and 0.064 Ci/ml L-[14C(U)]-glutamine (218 mCi/mmol; Ameri-
can Radiolabeled Chemicals, St. Louis, MO) or 0.5 mM Phe (Merck,
Darmstadt, Germany) and 0.064 Ci/ml L-[14C (U)]-phenylalanine (370
mCi/mmol; American Radiolabeled Chemicals), in the absence (control)
and in the presence of 0.2 nM recombinant rat leptin (Peprotech EC,
London, UK). After the incubation period, rings were washed in ice-cold
saline solution and radioactivity incorporated into the tissue was deter-
mined by liquid scintillation counting. Results are expressed as picomoles
amino acid per gram wet weight per minute (pmol/g per min).
Tissue preparation and short-circuit measurement. Animals were
euthanized by intraperitoneal pentobarbital overdose, and the proxi-
mal intestine was dissected out and rinsed in cold saline solution. The
mesenteric border was carefully stripped off using forceps and the
small intestine opened along this border and rinsed in Krebs-Ringer
bicarbonate solution (KRB). Four adjacent proximal samples were
mounted in modified Ussing chambers (Physiologic Instruments, San
Diego, CA). Exposed area was 0.50 cm2. The tissue samples were
bathed with 4 ml of carbogen-gassed KRB solution on each side.
Serosal KRB solution had the following composition (in mM): 115.4
NaCl, 5 KCl, 1.2 MgCl2, 0.6 NaH2PO4 25 NaHCO3, 1.2 CaCl2, and
10 glucose. In mucosal KRB solution, glucose was replaced by mannitol.
Each reservoir was gassed with 95% O2-5% CO2 and kept at constant
temperature of 37°C (pH at 7.35).
Electrogenic ion transport was monitored continuously as short-
circuit current (Isc) by using an automated voltage clamp apparatus
(DVC 1000; WPI, Aston, England) linked through a MacLab 8 to a
MacIntosh computer. Results were expressed as the intensity of the Isc
(A/cm2) or as the difference ( Isc) between the peak Isc after amino
acid challenge and the basal Isc measured just before the addition of
the amino acid. Leptin was added in either the mucosal or the serosal
bath 2–10 min before Gln challenge in the mucosal bath.
We found that there were no difference either in the quantitative
sodium-dependent Gln transport or in the effect of leptin between
middle jejunum and middle ileum, so the rest of studies were per-
formed using middle small intestine (jejunum-ileum).
Western blot analysis. Fasted rats were anesthetized by intraperi-
toneal administration of pentobarbital and laparotomized. Three small
intestinal loops (7-cm length) per rat were prepared as previously
described (16). They were filled with 3 ml of KRB-mannitol without
(2 loops) or with 1 nM leptin (1 loop) using a syringe equipped with
a 30–4/10 hypodermic needle (Acierinox; Vincent, Paris, France).
After 3-min in vivo incubation, the loop containing leptin and one
loop without leptin were filled with 1 ml of a 10 mM Gln solution
and again incubated for 3 min. This protocol was performed in four
different rats where the loops were treated in a randomized way. In
some rats, one loop was injected with leptin but without Gln. After
death, loops were removed and opened along the mesenteric border,
and the mucosa was scrapped off on ice with a glass blade. Brush-
border membrane vesicles (BBMV) were prepared from mucosa
scrapings as previously described (16). Protein concentration was
quantified using the BCA protein assay Kit (Pierce, Rockford, IL).
Solubilized proteins were resolved by electrophoresis on 12.5% SDS-
PAGE gels. The resolved proteins were transferred onto nitrocellulose
membranes and subjected to immunoblot analysis with a rabbit anti-
ASCT2 polyclonal antibody (AB 1352; Chemicon Millipore, Temecula,
CA) diluted 1:7,500, rabbit anti-B0AT1 at 1:500 (generous gift from
François Verrey), or with mouse monoclonal -actin antibody (sc-81178;
Santa Cruz Biotechnology, Santa Cruz, CA). The intensity of the immu-
noreactive bands detected by enhanced chemiluminescence (Pierce) was
quantified using NIH Image (Scion, Frederick, MD). -Actin was used as
loading control. The results were expressed in relation to control, and the
value of control was arbitrarily set to 1.
qRT-PCR analysis. Real-time PCR was used to examine the effect
of leptin on Gln-induced ASCT2 and B0AT1 gene expression. Rats
were anesthetized and laparotomized. Three small intestinal loops of
8 cm starting 15 cm from the cecum were prepared and filled with
1 nM leptin or saline. After 3-min in vivo incubation, loops were filled
with 10 mM Gln for 60 min. After this time, rats were killed, loops
were dissected and rinsed in saline, and mucosa was scrapped off on
ice. Total RNA was extracted from the mucosa samples with the
Trizol reagent (Qiagen, Valencia, CA). The first-strand cDNA was
synthesized by reverse transcription from 5 g of total RNA with
SuperScript II reverse transcriptase (Invitrogen, Cergy-Pontoise,
France). Quantification of cDNA was performed with a Light Cycler
System (Roche Diagnostics, Meylan, France) according to the man-
ufacturer’s instructions. Primers were as follows: rASCT2, f5=- CCA-
CATGCGAAAAGGAATCT-3= and r5=-CTCAAGAGCCCAATT-
TCCAA-3=; rB0AT1, f5=-TTACCAAGTCAGGGGGTGAG-3= and
r5=-GATGAGGGCTTCATGACGAT-3=; r18S, f5=-CCCTGGCCTT-
TGTACACACC-3= and r5=- GATCCGAGGGCGCTCACTA-3=.
They were designed with oligo 4 software and synthesized by Euro-
gentec (Southampton, UK). The comparative CT-method was used
for relative mRNA quantification of target genes, normalized to
protein 18S and a relevant control equal to 2-CT.
Chemicals. Recombinant murine leptin was purchased from Pre-
Protech EC (London, UK). All other chemical reagents were pur-
chased from Sigma. Leptin antagonist L39A/D40A (kind gift of Prof.
Arieh Gertler) was diluted in saline.
Statistical analysis. All results were expressed as means  SE.
Student’s t-test or one-way ANOVA with Tukey-Kramer multiple
comparison post test when appropriate were performed using Graph-
Pad Prism version 4.0 for Windows (GraphPad Software, San Diego,
CA) or SPSS. v.15. The level of significance was set at P  0.05.
RESULTS
Leptin inhibits glutamine uptake in everted rings. The effect
of leptin on Gln uptake was first studied on preparations of
everted intestinal rings after 15-min incubation. As shown in
Fig. 1A, uptake of 0.5 mM Gln was significantly reduced
(35%) by 0.2 leptin. The hormone also significantly reduced,
by 25%, uptake of 50 M Gln, a concentration close to the
K0.5 for ASCT2 (6) (Fig. 1B). To evaluate the contribution of
B0AT1 on Gln absorption at both concentrations, we examined
the effect of 25 mM Phe (specific substrate of B0AT1) on Gln
uptake. As depicted in Fig. 1A, Phe reduced 0.5 mM Gln
uptake by65%, indicating a higher contribution of B0AT1 on
Gln uptake compared with ASCT2. However, uptake of 50 M
was not inhibited by Phe (Fig. 1B), demonstrating that at this
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concentration only ASCT2 was contributing to Gln absorption.
The uptake of 0.5 mM Phe, assayed in the same tissue prepa-
ration as Fig. 1A, was found less than 10% of 0.5 mM Gln
uptake but was also inhibited (45%) by leptin (Fig. 1C).
Luminal leptin reduces glutamine-induced Isc. Leptin effect
was further investigated in Ussing chambers, a polarized sys-
tem that permits the access to either side of the tissue prepa-
ration. After the intestinal mucosa was isolated in the chamber
and allowed to reach a steady state (usually 40 min), tissues
were challenged with 10 mM Gln, which induced a rapid (less
that 2 min) and significant rise in Isc (23 A/cm2). The
increase in Isc was the result of the Na mucosal-to-serosal
movement that sustained the amino acid entry through sodium-
dependent amino acid transporter(s). In accordance with the
results obtained with intestinal rings (Fig. 1, A and C), 10 mM
Phe induced a small Isc, which was 12% of that for Gln
(Fig. 2A). Luminal addition of 10 mM Ala also significantly
raised Isc (Isc 15 A/cm2), whereas no change in Isc was
observed after 10 mM methyl aminoisobutyric acid (data not
shown), indicating the absence of system A participation in the
electrogenic uptake of Gln.
Again, in line with the data obtained with intestinal rings
(Fig. 1A), 20 mM Phe reduced the Gln-induced Isc by 70%
when it was added to the mucosal bath 3 min before 10 mM
Gln challenge (Fig. 2B) and leptin (10 nM) inhibited by 60%
Gln and Ala-induced Isc (Fig. 2C).
Inhibition of 10 mM Gln transport across intestinal mucosa,
following rapid incubation with leptin in the mucosal reservoir,
was found to be concentration dependent (Fig. 2D). Inhibition
was significant with 0.01 nM (30%), maximal for 10 nM
(80%), and decreased with 100 nM leptin up to 50%. The
concentration producing a half-maximal inhibition of Gln trans-
port (IC50) was 0.1 nM (Fig. 2D). Leptin (10 nM) reduced the Isc
induced by 30 mM Gln (26% inhibition, P  0.05) and also the
small Isc induced by 1 mM Gln although, in this case, the
inhibition did not reach statistical significance (data not shown).
Mucosal vs. serosal leptin. The possible effect of leptin on
Gln-induced Isc acting from the serosal side was also studied in
Ussing chambers. As shown in Fig. 2E, 10 nM leptin after 2
min in the serosal bath also decreased the 10 mM Gln-induced
Isc by 40%. This decrease, however, was smaller than that
produced by the hormone acting from the mucosal side, which
was around 80%. After 10 min, leptin from the serosal side had
no more inhibitory effect while it was still active from the
mucosal side (50% inhibition).
Leptin inhibition of glutamine transport is blocked by leptin
receptor antagonist. To examine whether the inhibitory effect
of leptin was dependent on leptin receptor, we studied the
effect of L39A/D40A, a mutated leptin-based peptide acting as
a leptin antagonist (26). As shown in Fig. 2F, addition of 50
nM L39A/D40A to the mucosal bath immediately before 10
nM leptin reversed leptin inhibition of Gln-induced Isc,
whereas 5 nM L39A/D40A had no effect.
Leptin reduces glutamine-induced ASCT2 and B0AT1 pro-
tein expression. Western blot assays were performed to investi-
gate whether leptin could modify the expression in the plasma
membrane of ASCT2 and B0AT1 transporters. As shown in
Fig. 3, incubation of the intestinal loops with 10 mM Gln during
3 min increased the presence of ASCT2 and, in a lesser extent, of
B0AT1 in the BBMV (Fig. 3, A and B). This increase was
inhibited when the loops had been previously incubated with 1
nM leptin for 3 min, showing that leptin reduced Gln-induced
ASCT2 and B0AT1 expression in the plasma membrane.
Fig. 1. Effect of leptin on glutamine (Gln) and phenylalanine (Phe) uptake by
everted intestinal rings. Uptake of 0.5 mM Gln (A), 50M Gln (B), or 0.5 mM Phe
(C) was measured in the absence or presence of 0.2 nM leptin after 15-min
incubation. Uptake of Gln was also measured in the presence of 25 mM Phe (A and
B). Experiments in A and C were performed in the same experimental group. The
results are expressed as means  SE; ***P  0.001 (n  6–18 from 3 animals).
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Leptin reduces glutamine-induced ASCT2 and B0AT1 mRNA
expression. Finally, the effect of luminal leptin on Gln-
induced ASCT2 and B0AT1 gene expression was studied.
Luminal infusion of 10 mM Gln for 60 min markedly
increased the level of ASCT2 and B0AT1 mRNA (6.7-fold
and 2.8-fold, respectively compared with their relative con-
trols; Fig. 4, A and B). When the intestinal loops were first
incubated with 1 nM leptin for 3 min before the Gln
infusion, the increase in ASCT2 and B0AT1 mRNA was
significantly reduced (55%). These results indicate that
leptin can also regulate Gln-induced ASCT2 and B0AT1
mRNA expression.
DISCUSSION
The present results demonstrate that, in rat intestine, leptin
inhibits the absorption of Gln and the protein and mRNA
expression of ASCT2 and B0AT1, the two major Gln trans-
Fig. 2. Leptin inhibition of glutamine induced
short-circuit current (Isc) in Ussing chamber.
A: Isc induced by 10 mM Gln, alanine (Ala),
and Phe (n  8–29). B: effect of 20 mM Phe
on 10 mM glutamine-induced Isc (n  4).
C: effect of 10 nM mucosal leptin on Isc
induced by 10 mM Gln or Ala. D: dose re-
sponse for mucosal leptin inhibition of Gln-
induced Isc. Leptin was added in the mucosal
bath 2 min before tissues were challenged with
10 mM Gln. Values for Isc were standardized
to control value. Each point represents the
mean SE of 4–6 noncumulative values from
4 separate experiments. E: effect of serosal
leptin (sx) vs. mucosal leptin (mq) at 10 nM
concentration on 10 mM Gln-induced Isc (con-
trol) (n 6). *P 0.05 vs. control; #P 0.05
vs. 2 min mq. F: action of leptin is receptor
specific; leptin antagonist L39A/D40A was
added to the mucosal bath 5 min before the
addition of leptin, and 3 min later tissues were
challenged in the mucosal side with 10 mM
Gln (n  6).
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porters in the apical membrane of the enterocytes (6), and that
this effect is a clear result of the luminal action of the hormone.
Gln, the most abundant amino acid in the body, plays a
central role in interorgan nitrogen transfer (13). Circulating
Gln concentration is maintained at a relatively constant level,
which is critical to avoid Gln depletion in blood and organ
dysfunction. The small intestine is the most important organ
for the supply of exogenous Gln to the body. Gln is also the
major fuel for intestine absorptive cells. Though the transport
systems for the entry of L-glutamine by intestinal epithelia cells
have been studied in different animal models (6), its regulation
by hormones and peptides is not yet completely understood.
Growth hormone (GH) and epidermal-growth factor (EGF) can
enhance intestinal Gln uptake (27), and a possible hormonal
stimulation of ASCT2 in vivo has been suggested (24).
Leptin is now well documented as an important regulator of
nutrient transporters from the apical membrane of the entero-
cytes. Indeed, leptin was shown to control butyrate MCT-1-
mediated absorption (10) and di-/tripeptide transporter PepT-1
(9) and modulate the activity of glucose and fructose transport-
ers through its action on SGLT1 (16, 19, 21), GLUT2, and
GLUT5 (25). A significant role for leptin in controlling active
transport of Gln was previously established in human placental
villous fragments where leptin stimulates the activity of system
Fig. 4. Effect of leptin on Gln-induced ASCT2 and B0AT1 gene expression.
Total RNA was extracted from mucosa of NaCl-treated (control), 1 nM
leptin-treated, and 10 mM Gln-treated (60 min) intestinal loops, and ASCT2
(A) and B0AT1 (B) mRNA expression were analyzed by RT-PCR. Results are
expressed as ratio of transporter/r18S mRNA expression in relation to control
and presented as means  SE of 3–4 rats per experimental group. *P  0.05;
**P  0.01, and ***P  0.001 vs. control; #P  0.05 vs. Gln.
Fig. 3. Effect of luminal leptin on Gln-induced expression of ASCT2 and
B0AT1 proteins in brush-border membrane (BBM). BBM vesicles were
obtained from mucosa of NaCl-treated (control), 1 nM leptin-treated, and 10
mM Gln-treated (3 min) intestinal loops, and ASCT2 (A) and B0AT1 (B)
protein expression were analyzed by Western blot. Representative Western
blot images are shown. Intensity of the immunoreactive bands was quantified
and expressed in relation to control. Results are expressed as means  SE for
3–4 rats per experimental group. **P  0.01 and ***P  0.001 vs. control.
#P  0.05 vs. Gln.
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A, thus controlling the availability of this important fuel to
placenta cells (20).
Here, the functional studies were first performed in vitro
using everted intestinal rings. The same technique was used to
demonstrate for the first time that leptin inhibits sugar intestinal
transport (21). Even though with this technique the mucosa is
exposed to the medium and the access of the hormone to the
enterocyte is mostly through the apical membrane, a possible
basolateral action of leptin could not be discarded. Therefore,
we further measured Gln transport in Ussing chambers, where
contribution of mucosal vs. serosal leptin could be distinctly
examined and mucosal-to-serosal Gln entry could be followed
as sodium-induced Isc. As observed with intestinal rings, leptin
pretreatment from the mucosal side induced a rapid and
marked reduction of the Gln-induced Isc. This effect was
concentration dependent with characteristics of inhibition
found in the nanomolar range (16, 21). The effect of leptin
from the serosal side was found significantly less pronounced
and disappeared at the longest incubation time (10 min). These
results may reflect the fact that leptin exposed to the serosal
side needs to diffuse a few layers of muscle and connective
tissues before reaching its receptors on the basolateral mem-
brane of the enterocytes, with possible reduction of the effec-
tive concentration. In addition, the membrane surface area for
leptin action is smaller when it acts from the serosal side
compared with the apical side, and the distance between the
receptor and the Gln transporters is higher. After 10 min, the
lack of leptin action from the serosal side can be also related to
the decrease of its effect from the apical side.
The Ussing chamber technique mimics the relevant action of
leptin, which is produced and secreted by gastric cells (1, 11)
together with its soluble receptor (12) and can flow along the
digestive lumen to reach the small intestine and act as a
physiological modulator. In fact, using leptin mutein, a leptin
receptor antagonist (26), we demonstrate that this modulation
requires an effective interaction of leptin with its specific
receptor located at the BBM of the small intestine (3, 9).
Interestingly, a recent report shows that, in leptin receptor-
deficient obese Zucker rats, Gln transport is highly increased
(29). This is in line with the inhibitory action of leptin as a
regulator of the Gln uptake here reported. It is tempting to
speculate, therefore, that leptin may act as a brake on the entry
of Gln, possibly in balance with another stimulating hormone
(i.e., GH or EGF). Interestingly, this leptin-induced action is
apparently different from the one recently proposed for angio-
tensin II that inhibits intestinal glucose uptake but not amino
acid transport under normal and diabetic conditions (30, 31).
In the intestine, Gln transport is assumed to be predomi-
nantly achieved by the sodium-dependent transporter B0AT1
(28). In rat intestinal rings, uptake of Phe, a specific substrate
of B0AT1, was also inhibited by leptin, indicating that B0AT1
was a target for the hormone. Interestingly, Phe uptake was
very low compared with Gln uptake at the same concentration,
which can be explained by the fact that B0AT1 shows lower
affinity for its substrates (K0.5 ranging from 1.4 to 4 mM)
compared with ASCT2 (K0.520 M) (6). Nevertheless, 25
mM Phe was able to inhibit by 65% Gln uptake, suggesting
a higher contribution of B0AT1 on Gln absorption in rat
intestine under this experimental condition. By employing
Ussing chamber, we also found that Phe-induced Isc was lower
compared with the Gln-induced Isc. Aside from B0AT1,
ASCT2 is the other sodium-dependent Gln transporter present
in the apical membrane of small intestine (6). From the func-
tional studies using 50 M Gln (concentration at which only
ASCT2 is responsible for Gln absorption), we also demonstrate
that ASCT2 is regulated by leptin.
To assess directly the presence of the two Gln transporters in
rat BBM and responsiveness to luminal substrate and/or leptin,
we further used biochemical and molecular approaches. Our
results clearly indicate that, in the basal condition, both B0AT1
and ASCT2 are present in rat BBM. Their expression in the
membrane can be rapidly increased by luminal Gln, and this
increase can be reduced by leptin at nanomolar range. Inter-
estingly, the ratio of ASCT2/B0AT1 protein expression in the
basal state was low (Fig. 3) and confirmed the reported pre-
dominance of B0AT1 in intestinal BBM (28). However, after
luminal challenge with Gln, more ASCT2 than B0AT1 protein
was observed to swing into the BBM. These biochemical data
would support a major importance of ASCT2 on Gln uptake in
rat intestine. However, because of the differences in the exper-
imental conditions, it is not possible to compare the functional
and biochemical results to draw conclusions about which
transporter is the principal in Gln entrance in the enterocytes.
Nevertheless, both functional and biochemical data hallmark
the contribution of ASCT2 and B0AT1 transporters in Gln
uptake.
We further demonstrated that leptin, in addition to its effect
on posttranslational regulation, can rapidly trigger transcrip-
tional control of the two Gln transporters. Thus leptin inhibits
the Gln-induced increase of ASCT2 and B0AT1 mRNA levels.
Regulation of ASCT2 gene expression by Gln was previously
reported in hepatic epithelial cells (7). The stimulation of
expression in response to Gln was shown to involve, in part,
binding of FXR/RXR to the ASCT2 promoter (8).
In summary, we demonstrate that luminal leptin can modu-
late the intestinal activity and expression of the Gln transport-
ers ASCT2 and B0AT1 in the apical membrane of the entero-
cytes. Because Gln is known to have both acute and chronic
effects on cell metabolism and function (13), the present
findings of leptin involvement in the modulation of Gln uptake
in both short- and long-term mode of action are believed to be
of major importance for the biology of intestinal cells.
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